Evidence map›Paper›PMID 40571832›Full record

ReviewCurrent gastroenterology reports2025

Advances in Diagnostics for the Evaluation of Neurogastroenterology & Motility Disorders: Are They Ready for Prime Time?

Lavanya Viswanathan, Baharak Moshiree

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current gastroenterology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lavanya ViswanathanUniversity of Texas MD Anderson Cancer Center, Houston, TX, USA. LViswanathan@mdanderson.org.
Baharak MoshireeAtrium Health, Charlotte, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewDisorders of Gut-Brain Interaction affect over 40% of patients and comprise a significant health-care resource burden. Much of the frustration for both patients and physicians is that many of the disease entities have overlapping symptoms and this leads to delay in diagnosis and in depth testing. RECENT

findingsAdvances in motility testing modalities have focused more on precision models which can enhance our understanding of patient symptoms. Many of these newer technologies focus on outpatient evaluations which can be transmitted for analysis to the physician, which can decrease healthcare utilization and improve patient convenience and satisfaction. We review several emerging technologies in order to familiarize the reader with the exciting advances in the field of Neurogastroenterology and Motility.

Indexed as

Gastrointestinal DiseasesGastrointestinal MotilityHumansCapsule based technologyDisorders of gut-brain interactionGastric function testingMicrobiomeMotility testing

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.